Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

8.20
Delayed Data
As of 3:53pm ET
 -0.04 / -0.49%
Today’s Change
5.65
Today|||52-Week Range
9.24
+9.33%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Imprimis Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +46.34% increase from the last price of 8.20.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Imprimis Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.33
Sales
$2.2M
Reporting Date
Sep 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually -14.41%
 
 
 
 

Sales

Growthquarterly 40.75%
 
 
 
 
 
 
Growthannually 664.47%
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account